Cabinet of Ministers Regulations No. 1025 in Riga 2009 September 8 (pr. No 56 42) amendments to the Cabinet of Ministers of 5 January 1999, regulations No 7 "infectious disease registration order" Issued in accordance with the epidemiological safety law of article 10 and article 14, paragraph 4, first subparagraph 1. make Cabinet 5 January 1999 regulations No 7 "order of registration of infectious diseases" (Latvian journal, 1999, 5/6.nr.; 2002, 97. nr.; 2003, 111 no; 2004, nr. 66; 2006, 2007 57 no; 108. no; in 2008, 100. No.) the following amendments: 1. replace the words in subparagraph 1.2. "State Agency" public health agency "(hereinafter referred to as the public health agency)" with the words "public agency" Infektoloģij Center "(hereinafter referred to as the Infektoloģij Centre of Latvia)";
1.2. the express 3.1. subparagraph by the following: "3.1. Infektoloģij Center and the region's epidemiologists;";
1.3. deleting subparagraph of 3.4;
1.4 delete subparagraph 6.5;
1.5. make point 7 by the following: "7. If a communicable disease is detected or occur in professionally reasonable suspicion about the patient being infected with infectious diseases, treatment of persons: 7.1 for this rule group 1 of annex 2 of the above diseases immediately any time of the day by telephone and in writing, notify the Centre of the Latvian Infektoloģij, by sending the completed express notification form by fax, by mail, by courier or by electronic means, and on reporting of the facts made by the patient's medical record documentation;
7.2. the provisions of this annex 2 Group 2 of the diseases referred to in 24 hours by telephone and in writing, notify the Centre of the Latvian Infektoloģij the region, by sending epidemiologists fill the urgent notification form by fax, by mail, by courier or by electronic means, and on reporting of the facts made by the patient's medical record documentation;
7.3. for this rule group 3 of annex 2 of the above diseases (except human immunodeficiency virus (HIV) infection, AIDS and tuberculosis) within three days in writing notify the Latvian Center of the Infektoloģij region, by sending epidemiologists fill the urgent notification form by fax, by mail, by courier or by electronic means, and on reporting of the facts made by the patient's medical record documentation;
7.4. the human immunodeficiency virus (HIV) infection, AIDS and tuberculosis within three days in writing or electronically notify the Infektoloģij Centre of Latvia to fill the medical records according to the laws and regulations on the treatment of medical institutions and the accounting records of the documentation procedure. ";
1.6. to replace paragraph 7.3, the words "the relevant agencies of the public health branch" with the words "Infektoloģij Center of the region concerned"; epidemiologists
1.7. to replace paragraph 8, the words "the public health agency's branch" with the words "Latvian Center of the Infektoloģij region of epidemiologists ';
1.8. the deletion of paragraph 9;
1.9. the introductory part of paragraph 9.1 to replace the words "Government agency" Latvian National acre ditācij ' "with the words" limited liability company "standardization, metrology and accreditation centre";
1.10. Express 2. section 9.1 the following: "2.9.1 identification and tipēšan, if dedicated micro-culture is Not a isseri meningitidis.";
1.11. delete 9.1 9.1.3 and 4.
1.12. Express 9.2 8. subparagraph by the following: "9.2 8. avian influenza virus or other influenza virus, which the World Health Organization considers the possible pandemic agents;"
1.13. Supplement 2. section 9.3 the second sentence as follows: "in the event of an outbreak of diseases referred to (10 or more cases) microbiology laboratory Manager or his authorised person aligned with the Centre of the Latvian Infektoloģij the number of samples to be delivered to the reference laboratories for approval.";
1.14. supplement with 9.4 points as follows: "If a person has treatment 9.4 professionally justified suspicion of the patient's infection with any of the provisions listed in annex 3 and communicable diseases, medical person ensures patient laboratory investigations of any of the provisions specified in annex 3 of the pathogen detection methods. In the event of an outbreak (10 or more cases) treatment of accordance with Latvian Center of the Infektoloģij region in the laboratory the patient epidemiologists. ";
1.15. make paragraph 10 by the following: "10." Microbiology Laboratory Manager or his authorised representative shall report to the Centre the Latvian Infektoloģij the epidemiologists to the region for this rule in annex 3 infection agents presence of direct or indirect detection of human material tested sample or approving them other laboratory: 10.1 1. pathogens listed in the group immediately by telephone and record the fact of reporting;
10.2. for Group 2 pathogens listed in 72 hours, sending fill the urgent notification form by fax, by mail, by courier or by electronic means, and shall record the fact of reporting. "
1.16. in point 10.1 replace the words "the public health agency" with the words "Infektoloģij Center";
1.17. supplement with 10.2 point as follows: "If the head of the laboratory of Microbiology 10.2 or his authorized person under these rules laid down in paragraph 10 of the report on this provision of the annex referred to in paragraph 17, the agent of detection of isseri Not gonorrhoea, urgent notification form indicating resistance against antimikrob means testing method and results, if such testing was performed.";
1.18. the deletion of paragraph 11;
1.19. make the following point 12.1: "12.1 these terms referred to in paragraph 3, the institution provides the European Parliament and of the Council of 24 September 1998 in decision 2119/98/EC on the network on the epidemiological surveillance and control of communicable diseases in the community, the European Commission of 22 December 1999, in decision 2000/57/EC on the early warning and response system for the prevention and control of communicable diseases in accordance with European Parliament and Council decision 2119/98/EC (notified under document C (1999) 4016) The Commission's 1999 22 December in decision 2000/96/EC on infectious diseases will be gradually included in the community network pursuant to European Parliament and Council decision 2119/98/EC (notified under document C (1999) 4015), Commission of 19 March 2002 in decision 2002/253/EC laying down case definitions for reporting communicable diseases to the community network under decision of the European Parliament and of the Council 2119/98/EC (notified under document C (2002) 1043) (2002/253/EC) The Commission's 17 July 2003 decision 2003/534/EC amending European Parliament and Council decision 2119/98/EC and decision 2000/96/EC as regards communicable diseases listed in those decisions and amending Decision 2002/253/EC as regards the case definitions for communicable diseases (notified under document C (2003) 2301) (text with EEA relevance) (2003/534/EC) the Commission of 17 April 2003 in decision 2003/542/EC amending Decision 2000/96/EC as regards the operation of dedicated surveillance networks (notified under document C (2003) 2522) (text with EEA relevance) (2003/542/EC) the Commission of 18 December 2007 by decision 2007/875/EC amending European Parliament and Council decision 2119/98/EC and decision 2000/96/EC as regards these decisions these communicable diseases (notified under document number c(2007) 6355) Of the Commission of 28 April 2008. in decision 2008/351/EC amending Decision 2000/57/EC as regards events to be reported via the early warning and response system for the prevention and control of communicable diseases (notified under document number c(2008) 1574), of the Commission of 28 April 2008. in decision 2008/426/EC amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the community network under decision of the European Parliament and of the Council 2119/98/EC (notified under document number C (2008) 1589), a Commission of 2 April 2009. in decision 2009/312/EC amending Decision 2000/96/EC as regards communicable diseases surveillance network of specialised (notified under document number C (2009) 2351) and the Commission of 30 April 2009. in decision 2009/363/EC amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the community network under decision of the European Parliament and of the Council 2119/98/EC (notified under document number c(2009) 3517) the epidemiological information exchange with European Union Member States the epidemiological surveillance institutions. ";
1.20. supplement with 14.1 points as follows: "14.1 2009. October 1 this rule 7.4. in the case referred to in subparagraph treatment for patients who are diagnosed with tuberculosis, complete medical records according to the legislation on medical treatment institutions and accounting procedures and the documentation records within three days, send to the tuberculosis and lung disease national agency.";
1.21. Replace annex 1, the words "the public health agency's branch" with the words "Latvian Center of the Infektoloģij region of epidemiologists ';
1.22. in annex 2:1.22.1. Express name as follows: "the infectious disease to be registered";

1.22.2. Delete box 4 and two apakšail;
1.22.3. make paragraph 6 by the following: ' 76.
Invasive Haemophilus infuenza disease 2 "delete point 1.22.4.16;
1.22.5. Add to paragraph 26, after the word "disease" with the words "t.sk. Chlamydia Venereum (lymphogranulom-venere) ";
1.22.6. adding to 49 after the word "flu" by the words "or other influenza, caused by a virus, which the World Health Organization considers the possible cause of the pandemic (until such time as will be found in the persistent spread of influenza)";
1.22.7. delete paragraph 54;
1.22.8. replace paragraph 69, the words "URt.sk." by the words "and approved";
1.22.9. supplemented with paragraph 72 of annex by the following: ' 72.
Invasive pneumococcal disease in 3 "make 1.23. Annex 3 as follows:" 3. the Cabinet of Ministers of 5 January 1999, regulations No 7 predetermines laboratory findings infectious pathogens, detection methods and the samples to be examined no PO box
Agent of infectious disease (infectious disease) method the clinical material group i. bacterial infectious diseases 1.
Bacillus anthrac (liesassērg, Siberian cattle plague) isolation is not defined in the 1.
nucleic acid from a ** not defined 1.
2. Bordetella pertussis (whooping cough) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
specific antibody response serum is not reported 3.
Brucella spp. (brucellosis) isolation is not defined * 2.
specific antibody response in serum * 2.
4. Campylobacter spp. (Campylobacter) isolation of faeces, blood 2.
5. Chlamydia trachomatis (Chlamydia proposed a sexually transmitted disease, including lymphogranulom venere, the LGV) isolation from the anoģenitāl tract or conjunctiva 2.
direct response is not defined imūnfluorescenc ** 2.
nucleic acid from a * not defined * 2.
LGV: isolation or nucleic acid detection with additional serovariant L1, L2 or L3 (genovariant) identified no ** 2.
6. Clostridium botulinum (botulism) isolation of stools (infant botulism), material from the wound (wound botulism) 2.
Botulinum Toxins detection is defined ** 2.
7. Clostridium tetan (tetanus) isolation from infection in the affected places 2.
tetanus toxin detection serum 2.
Corynebacterium diphtheriae 8, Corynebacterium ulcerans (diphtheria and diphtheria agent carrying a) toxin produced C diphtheriae or c. ulcerans. is isolation not defined * 2.
9. Coxiell-burnetii (Q fever) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
specific antibody response (IgG or IgM phase II) serum is reported 10.
Escherichia coli, Shiga toxin that produces/verotoksīn (STEC/VTEC) (Enterohaemorrhagic Escherichia coli in the proposed ešerihioz (STEC/VTEC)) is not defined in isolation.
(s) a gene stx1 or stx2 nucleic acid from a * not defined * 2.
Shiga toxin-free detection is defined ** 2.
specific antibody response in serum * 2.
11. Francisella tularensis (tularemia) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
specific antibody response in serum * 2.
12. Haemophilus influenza (invasive Haemophilus influenza a infection) usually sterile isolation material 2.
nucleic acid from a normally sterile material 2.
13. the pneumophil Legionell (Legionnaires ' disease) isolation (Legionell spp.)
respiratory secretions, the other usually sterile material 2.
nucleic acid detection (Legionell spp.)
* not defined * 2.
Antigen (the pneumophil Legionell) urine, respiratory secretions, lung tissue 2.
specific antibody response against Legionell spp.
serum 2.
14. Leptospira interrogans (leptospirosis) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
determination method of imūnfluorescenc not defined * 2.
specific antibody response in serum * 2.
15. Listeria monocytogenes (listeriosis) normally sterile isolation material 2.
isolation of non-sterile material, usually taken from the fruit, not the life of the child born, the newborn child or mother during delivery or within 24 hours after those 2.
16. Methicillin resistant S. aureus (MRSA), vancomycin-resistant s. aureus (BRING) isolation is not defined * 2.
17. the isseri Not gonorrhoea (gonococcal infection) is not defined in isolation.
nucleic acid from a * not defined * 2.
determination of nucleic acid probe without amplificēšan * not defined * 2.
gramnegatīv of intracellular diplococci (gonococcal) smear from the male urethra 2.
18. do not isseri the detection of n. meningitidis (meningococcal invasive disease) usually sterile isolation material 2.
nucleic acid from a normally sterile material, purple skin damage 2.
Antigen likvor 2.
gramnegatīv detection of diplococci microscopic likvor 2.
19. Salmonella species (salmonellosis and the agents carrying) isolation is not defined * 2.
20. Salmonella Typhi and salmonella paratyphii (typhoid and paratyphoid fever, typhoid and paratyphoid t.sk. agents carrying) isolation is not defined * 2.
21. species Shigella (Shigellosis and its agents carrying) isolation is not defined * 2.
22. Streptococcus pneumoniae (invasive pneumococcal disease) usually sterile isolation material 2.
nucleic acid from a normally sterile material 2.
Antigen from normally sterile material 2.
the Treponema pallidum 23 (syphilis) dark field microscopy of exudate damage tissue, and the newborn congenital syphilis in the case of the umbilical cord, the placenta also, nasal discharge 2.
direct response imūnfluorescenc to damage tissue, exudate, and the newborn congenital syphilis – also in the case of the umbilical cord, the placenta, the nasal discharge 2.
nucleic acid detection (PCR) of exudate or tissue damage 2.
Screening tests ***: treponēmāl tests (VDRL, RPR SED) blood, serum is not reported screening test ***: treponēmāl test (VDRL) baby likvor 2.
Screening test ***: demonstration of Treponema pallidum haemagglutination test (TPH) blood, serum is not reported screening test ***: demonstration of Treponema pallidum particle agglutination test (tmp) blood, serum is not reported IgM and/or IgG specific antibodies (confirmation test), blood serum 2.
24. Vibrio cholerae (cholera) isolation is not defined in the 1.
25. Yersinia enterocolitica and Yersinia pseudotuberculos (yersiniosis) isolation is not defined * 2.
26. Yersinia pestis (plague) isolation is not defined in the 1.
nucleic acid detection (F1 Antigen) is not defined in the 1.
specific antibody response (against Yersinia pestis F1 Antigen) serum 1.


II. Viral infectious diseases 1.
Hepatitis a virus (hepatitis A) nucleic acid from serum, stools 2.
specific antibody response in serum * 2.
Antigen stool 2.
2. Hepatitis B virus (hepatitis B) specific IgM antibody response to hepatitis B virus core Antigen serum not reported 3.
Hepatitis c virus (hepatitis C) nucleic acid from serum 2.
specific antibody response, which was approved by a different antibody test serum is not reported 4.
Yellow fever virus (yellow fever) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
Antigen is not defined * 2.
specific antibody response in serum * 2.
5. Involved (meningitis, encephalitis) isolation is not defined * 2.
specific antibody response in serum do not have to report the nucleic acid from likvor 2.
6. Epidemic mumps virus (mumps) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
specific antibody response characteristic for acute infection, serum, saliva for 2.
7. Type I and II Herpes Simplex viruses (herpes virus infection in anoģenitāl) is not defined in isolation.
direct response is not defined imūnfluorescenc ** 2.
nucleic acid from a * not defined * 2.
8. Lyss virus (rabies) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
direct response is not defined imūnfluorescenc ** 2.
specific antibody response to the virus neutralisation test for serum, likvor 2.
9. Rubella virus (rubella) isolation is not defined * 2.
nucleic acid from a * not defined * 2.
specific antibody response (IgG), serum saliva 2.
specific antibody response (IgM) serum 2.
10. Measles (measles) virus isolation is not defined * 2.
nucleic acid from a * not defined * 2.
specific antibody response characteristic for acute infection, serum, saliva for 2.
direct imūnfluorescenc reaction with monoclonal antibodies ** not defined 2.
11. Poliovīrus (polio) isolation is not defined in the 1.
12. Avian influenza virus or other influenza virus, which the World Health Organisation of a possible pandemic is considered the cause of isolation is not defined in the 1.
nucleic acid from a ** not defined 1.
specific antibody response serum 1.
13. West Nile fever virus (West Nile fever) isolation of blood, likvor 2.
nucleic acid from blood, likvor 2.
specific antibody response in serum, likvor 2.
14. SARA-(SARS) coronavir isolation and identification (RT-PCR) * not defined * 1.
nucleic acid from a ** not defined 1.

specific antibody response serum 1.
15. Variol (smallpox) virus isolation is not defined in the 1.
nucleic acid from a ** not defined 1.
Orthopox virus particles with electron microscopy identification is not defined in the 1.
16. the viruses that cause acute intestinal infections (such as rotavirus, a programme identifying norovirus, astrovīrus, adenovīrus) Antigen stool 2.
nucleic acid from stools 2.
17. viruses causing viral hemorāģisko in fever (viral haemorrhagic fevers) isolation is not defined in the 1.
nucleic acid from a ** not defined 1.


III. Parasitic infectious diseases 1.
Cryptosporid (Cryptosporidiosis) determination of Oocyst stools 2.
determination of intestinal parasites, small intestine biopsy material 2.
nucleic acid from stools 2.
Antigen stool 2.
2. Echinococcus spp. (echinococcosis) specific antibody response in serum * 2.
nucleic acid from a * not defined * 2.
3. the lambli Compatible (žiardiāz) cyst or determination of trofozoīt, duodenāl liquid stools, small intestine biopsy material 2.
Antigen stool 2.
4. Plasmodi spp.. (malaria) parasites, using light microscopy, a smear of blood 2.
nucleic acid from blood 2.
Antigen is not defined * 2.
5. the Toxoplasm manmad (toxoplasmosis) detection of t.gondii * not defined * 2.
nucleic acid from a * not defined * 2.
specific antibody response in serum * 2.
6. the Trichinella spp. (trichinosis)
Trichinella larvae in muscle biopsy for detection of tissue 2.
specific antibody response in serum * 2.
The notes.
1. the specific antibody response – unless otherwise indicated – IgM antibody presence if the patient recently, there has been no vaccination or diagnostically important specific antibody titre.
2. ** not defined – clinical material is determined by the type of treatment a person according to the progress of the disease and laboratory requirements.
3. Screening test ***-if diagnosed with syphilis, screening test by specific IgM and IgG class antibodies, or test-imūnfermentatīv test imūnblot test imūnfluorescenc test (FTA-ABS). "
 
2. These rules and point 1.22.2.1.3 shall enter into force on October 1, 2009.
Prime Minister Dombrovskis v. Minister of health b. Rosenthal is the Editorial Note: regulations shall enter into force with 12 September 2009.